Rigel Pharmaceuticals
RIGL
RIGL
121 hedge funds and large institutions have $528M invested in Rigel Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 52 increasing their positions, 21 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
12% more funds holding
Funds holding: 108 → 121 (+13)
0.51% more ownership
Funds ownership: 8.77% → 9.29% (+0.51%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
121
Holding in Top 10
1
Calls
$1.43M
Puts
$341K
Top Buyers
| 1 | +$20.3M | |
| 2 | +$15M | |
| 3 | +$12.9M | |
| 4 |
BC
Boxer Capital
San Diego,
California
|
+$12.2M |
| 5 |
Millennium Management
New York
|
+$11.1M |
Top Sellers
| 1 | -$4.72M | |
| 2 | -$2.63M | |
| 3 | -$1.62M | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$1.27M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$1.07M |